Little Mark P, McElvenny Damien M
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland, USA.
Environ Health Perspect. 2017 Feb;125(2):223-229. doi: 10.1289/EHP151. Epub 2016 Jun 10.
There are well-known associations of ionizing radiation with female breast cancer, and emerging evidence also for male breast cancer. In the United Kingdom, female breast cancer following occupational radiation exposure is among that set of cancers eligible for state compensation and consideration is currently being given to an extension to include male breast cancer.
We compare radiation-associated excess relative and absolute risks of male and female breast cancers.
Breast cancer incidence and mortality data in the Japanese atomic-bomb survivors were analyzed using relative and absolute risk models via Poisson regression.
We observed significant (p ≤ 0.01) dose-related excess risk for male breast cancer incidence and mortality. For incidence and mortality data, there are elevations by factors of approximately 15 and 5, respectively, of relative risk for male compared with female breast cancer incidence, the former borderline significant (p = 0.050). In contrast, for incidence and mortality data, there are elevations by factors of approximately 20 and 10, respectively, of female absolute risk compared with male, both statistically significant (p < 0.001). There are no indications of differences between the sexes in age/time-since-exposure/age-at-exposure modifications to the relative or absolute excess risk. The probability of causation of male breast cancer following radiation exposure exceeds by at least a factor of 5 that of many other malignancies.
There is evidence of much higher radiation-associated relative risk for male than for female breast cancer, although absolute excess risks for males are much less than for females. However, the small number of male cases and deaths suggests a degree of caution in interpretation of this finding. Citation: Little MP, McElvenny DM. 2017. Male breast cancer incidence and mortality risk in the Japanese atomic bomb survivors - differences in excess relative and absolute risk from female breast cancer. Environ Health Perspect 125:223-229; http://dx.doi.org/10.1289/EHP151.
众所周知,电离辐射与女性乳腺癌有关,新出现的证据也表明其与男性乳腺癌有关。在英国,职业性辐射暴露后发生的女性乳腺癌属于可获得国家赔偿的癌症类型,目前正在考虑将范围扩大到包括男性乳腺癌。
我们比较男性和女性乳腺癌与辐射相关的超额相对风险和绝对风险。
通过泊松回归,使用相对风险和绝对风险模型分析了日本原子弹爆炸幸存者中的乳腺癌发病率和死亡率数据。
我们观察到男性乳腺癌发病率和死亡率存在显著的(p≤0.01)剂量相关超额风险。对于发病率和死亡率数据,男性乳腺癌发病率的相对风险分别比女性高约15倍和5倍,前者接近显著水平(p = 0.050)。相比之下,对于发病率和死亡率数据,女性的绝对风险分别比男性高约20倍和10倍,两者均具有统计学意义(p < 0.001)。在相对或绝对超额风险的年龄/暴露后时间/暴露时年龄修正方面,没有迹象表明性别之间存在差异。辐射暴露后男性乳腺癌的病因概率至少比许多其他恶性肿瘤高5倍。
有证据表明,男性乳腺癌与辐射相关的相对风险远高于女性,尽管男性的绝对超额风险远低于女性。然而,男性病例和死亡人数较少,这表明在解释这一发现时需要一定程度的谨慎。引用文献:Little MP, McElvenny DM. 2017. 日本原子弹爆炸幸存者中的男性乳腺癌发病率和死亡风险——与女性乳腺癌超额相对风险和绝对风险的差异。《环境健康展望》125:223 - 229;http://dx.doi.org/10.1289/EHP151 。